Structural  	Structural  	 JJ	B-NP
Studies  	Studies  	 NNS	I-NP
of  	of  	 IN	O
Component  	Component  	 NNP	O
of  	of  	 IN	O
Lysoamidase  	Lysoamidase  	 NNP	B-NP
Bacteriolytic  	Bacteriolytic  	 NNP	I-NP
Complex  	Complex  	 NNP	I-NP
from  	from  	 IN	O
Lysobacter  	Lysobacter  	 NNP	B-NP
sp 	sp 	 NN	I-NP
.  	.  	 .	O
XL1  	XL1  	 CD	B-NP
The  	The  	 DT	O
lysoamidase  	lysoamidase  	 JJ	B-NP
bacteriolytic  	bacteriolytic  	 JJ	I-NP
complex  	complex  	 NN	I-NP
( 	( 	 -LRB-	O
LBC 	LBC 	 NNP	B-NP
)  	)  	 -RRB-	O
comprising  	comprising  	 VBG	O
five  	five  	 CD	O
enzymes  	enzymes  	 NNS	O
( 	( 	 -LRB-	O
L1-L5 	L1-L5 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
secreted  	secreted  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
culture  	culture  	 NN	B-NP
liquid  	liquid  	 NN	I-NP
by  	by  	 IN	O
gram-negative  	gram-negative  	 JJ	B-NP
bacterium  	bacterium  	 NN	I-NP
Lysobacter  	Lysobacter  	 NNP	I-NP
sp 	sp 	 NN	I-NP
.  	.  	 .	O
XL1 	XL1 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
medicinal  	medicinal  	 JJ	B-NP
agent  	agent  	 NN	I-NP
lysoamidase  	lysoamidase  	 NN	I-NP
has  	has  	 VBZ	O
a  	a  	 DT	O
broad-antimicrobial  	broad-antimicrobial  	 JJ	B-NP
spectrum 	spectrum 	 NN	I-NP
.  	.  	 .	O
Bacteriolytic  	Bacteriolytic  	 FW	B-NP
protease  	protease  	 FW	I-NP
L1  	L1  	 FW	I-NP
belongs  	belongs  	 VBZ	O
to  	to  	 TO	O
the  	the  	 DT	O
LBC 	LBC 	 NNP	B-NP
.  	.  	 .	O
Recombinant  	Recombinant  	 NNP	B-NP
L1  	L1  	 NNP	I-NP
protease  	protease  	 NN	I-NP
of  	of  	 IN	I-NP
Lysobacter  	Lysobacter  	 NNP	I-NP
sp 	sp 	 NN	I-NP
.  	.  	 .	O
XL1  	XL1  	 NNP	B-NP
was  	was  	 VBD	O
expressed 	expressed 	 VBN	O
,  	,  	 ,	O
purified  	purified  	 VBG	O
to  	to  	 TO	O
homogeneity  	homogeneity  	 VB	O
and  	and  	 CC	O
crystallized 	crystallized 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
X-ray  	X-ray  	 NN	B-NP
structure  	structure  	 NN	I-NP
of  	of  	 IN	O
L1  	L1  	 CD	O
at  	at  	 IN	O
1.35 Å  	1.35 Å  	 CD	O
resolution  	resolution  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
determined  	determined  	 VBN	O
using  	using  	 VBG	O
the  	the  	 DT	O
synchrotron  	synchrotron  	 JJ	O
data  	data  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
replacement  	replacement  	 NN	I-NP
method 	method 	 NN	I-NP
.  	.  	 .	O
L1  	L1  	 NNP	B-NP
protease  	protease  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
thermostable  	thermostable  	 NN	B-NP
whose  	whose  	 WP$	O
thermal  	thermal  	 JJ	B-NP
unfolding  	unfolding  	 JJ	I-NP
proceeds  	proceeds  	 NNS	I-NP
in  	in  	 IN	O
one  	one  	 CD	O
step  	step  	 NN	O
without  	without  	 IN	O
forming  	forming  	 VBG	O
stable  	stable  	 JJ	O
intermediates 	intermediates 	 NN	O
.  	.  	 .	O
Structural  	Structural  	 JJ	B-NP
information  	information  	 NN	I-NP
concerning  	concerning  	 VBG	I-NP
L1  	L1  	 NNP	I-NP
will  	will  	 MD	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
new-generation  	new-generation  	 NN	B-NP
antimicrobial  	antimicrobial  	 NN	I-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
whose  	whose  	 WP$	O
application  	application  	 NN	O
will  	will  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
accompanied  	accompanied  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
selection  	selection  	 NN	O
of  	of  	 IN	O
resistant  	resistant  	 JJ	O
microorganisms 	microorganisms 	 NN	B-NP
.  	.  	 .	O
